Related Experiment Video
Updated: Jun 17, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia
1Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Abstract:
Microglial activation has been implicated as one of the causative factors for neuroinflammation in various neurodegenerative diseases. The sphingolipid metabolic pathway plays an important role in inflammation, cell proliferation, survival, chemotaxis, and immunity in peripheral macrophages. In this study, we demonstrate that sphingosine kinase1 (SphK1), a key enzyme of the sphingolipid metabolic pathway, and its receptors are expressed in the mouse BV2 microglial cells and SphK1 alters the expression and production of proinflammatory cytokines and nitric oxide in microglia treated with lipopolysaccharide (LPS). LPS treatment increased the SphK1 mRNA and protein expression in microglia as revealed by the RT-PCR, Western blot and immunofluorescence. Suppression of SphK1 by its inhibitor, N, N Dimethylsphingosine (DMS), or siRNA resulted in decreased mRNA expression of TNF-alpha, IL-1beta, and iNOS and release of TNF-alpha and nitric oxide (NO) in LPS-activated microglia. Moreover, addition of sphingosine 1 phosphate (S1P), a breakdown product of sphingolipid metabolism, increased the expression levels of TNF-alpha, IL-1beta and iNOS and production of TNF-alpha and NO in activated microglia. Hence to summarize, suppression of SphK1 in activated microglia inhibits the production of proinflammatory cytokines and NO and the addition of exogenous S1P to activated microglia enhances their inflammatory responses. Since the chronic proinflammatory cytokine production by microglia has been implicated in neuroinflammation, modulation of SphK1 and S1P in microglia could be looked upon as a future potential therapeutic method in the control of neuroinflammation in neurodegenerative diseases.
Insights
Sphingosine kinase 1 (SphK1) regulates microglial inflammation. Inhibiting SphK1 reduces proinflammatory cytokines, while adding sphingosine 1 phosphate (S1P) enhances them, suggesting therapeutic potential for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Immunology
- Biochemistry
Background:
- Microglial activation contributes to neuroinflammation in neurodegenerative diseases.
- The sphingolipid metabolic pathway is crucial for inflammatory responses in immune cells.
Purpose of the Study:
- To investigate the role of sphingosine kinase 1 (SphK1) in microglial activation and neuroinflammation.
- To determine the effects of SphK1 modulation and sphingosine 1 phosphate (S1P) on proinflammatory cytokine production in microglia.
Main Methods:
- Utilized mouse BV2 microglial cells.
- Assessed SphK1 expression via RT-PCR, Western blot, and immunofluorescence.
- Inhibited SphK1 using N, N Dimethylsphingosine (DMS) or siRNA.
- Measured proinflammatory cytokine (TNF-alpha, IL-1beta) and nitric oxide (NO) production.
Main Results:
- LPS treatment upregulated SphK1 expression in microglia.
- SphK1 inhibition decreased the expression and release of TNF-alpha, IL-1beta, and iNOS.
- Exogenous S1P administration enhanced the production of TNF-alpha, IL-1beta, and NO in LPS-activated microglia.
Conclusions:
- SphK1 plays a key role in regulating microglial inflammatory responses.
- Modulating SphK1 and S1P in microglia offers a potential therapeutic strategy for neuroinflammation in neurodegenerative diseases.
Related Concept Videos
Nitric Oxide Signaling Pathway
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply
IP3/DAG Signaling Pathway